Please join us in Paris at ESC Mon Sept 2nd 6-8:30pm to discuss LBCT in #heartfailure PARAGON and PIONEER with @ShelleyZieroth +@JustinEzekowitz featuring Dr. Scott Solomon. Everyone welcome!! Register at: https://t.co/wEbb5A8jtw @SCC_CCS @HFSA @lizswiggum @DktrV @AniqueDucharme https://t.co/W7bIvE5zsq

CHFS is looking for Board Members. Req'd to be members, attend+participate in Board mtgs at CHFS HF Update+CCC. ?'s to chfs@ccs.ca or call 1-877-569-3407 Ext. 418. Deadline July 8th, see link. @SCC_CCS_Trainee @SCC_CCS @ShelleyZieroth @DktrV @lizswiggum https://t.co/G6qmB9OCcZ https://t.co/51lnsMYTFx

Looking to connect with fellow #earlycareer #heartfailure specialists? Come to the HFSA Annual Scientific Meeting! In 2018, nearly 40% of attendees were early careers (0-5 years) #hf care providers. Sign up today>> https://t.co/mFasnFCYOo https://t.co/cNnVq3MPuT

?Furosemide: bolus vs continuous infusion (CI) DRAIN trial?? •Adv #HeartFailure •CI ?Faster decongestion& ?Greater diuretic response ?Without? incidence of WRF ? All received a bolus In the DOSE-AHF, CI was not preceded by a bolus loading dose ? https://t.co/AhmAYnjFPz https://t.co/qo2FXgdpOx

Happy Canada Day! @CanHFSociety @HeartandStroke @SCC_CCS @pumpinghearts @DktrV @ShelleyZieroth @lizswiggum @CCSPrez #heartfailure https://t.co/9P4TEieBMe

Excited to share new #COMMANDERHF data pub #openaccess in @escardio #FastTrack Stroke is common, even in HFrEF & sinus rhythm, disabling, & modifiable w/ low-dose #rivaroxaban. CHADS2VASc has modest discrimination in identifying stroke, similar to in AF https://t.co/S9sXxPlsJj https://t.co/hEGxLzrfOY

?Pathophysiology, diagnosis and management of peripartum cardiomyopathy A position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy By @escardio https://t.co/yxMxr26QHS https://t.co/c4Saw9bxgK

Heart Failure hospitalization is an often missed opportunity to initiate or uptitrate #GDMT, with little contemporary data. With @mustoma, @DktrV, and Nat Hawkins in @ESC_Journals, we described achievement of ≥50%, target dose, and contributing factors: https://t.co/AthG1MqdIW

Be the first to register! Give our historical champion @boneill2012 a run for his money! https://t.co/abmCd3a3P7

Adding #NTproBNP to the #EHMRG model improved its performance in risk stratifying patients with #HeartFailure at #emergency department @CVC_UAlberta @JustinEzekowitz https://t.co/BhirPukiIx https://t.co/d7i8NJd1rQ